SCHEMBL6125347

SCHEMBL6125347

Cc1cc(N)ccc1/N=N\c1ccc(/N=N\c2ccc(S(=O)(=O)O)cc2)cc1S(=O)(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SENP2 Q9HC62 6/20 0.61
SUMO2 P61956 4/20 0.61
SUMO1 P63165 4/20 0.61
SENP7 Q9BQF6 4/20 0.61
ATIC P31939 2/20 0.61
ENPP2 Q13822 2/20 0.55
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
ALDH1A1 P00352 3/20 0.52
KDM4E B2RXH2 2/20 0.52
CYP3A4 P08684 2/20 0.52
MAPT P10636 2/20 0.52
NPC1 O15118 1/20 0.52
CYP1A2 P05177 1/20 0.52
POLB P06746 1/20 0.52
RAB9A P51151 1/20 0.52
ATM Q13315 1/20 0.52
RPS6KA3 P51812 1/20 0.50
SENP1 Q9P0U3 4/20 0.47
SENP3 Q9H4L4 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15386712 0.93 SENP2 (0.58) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL6123725 0.92 ATIC (0.58) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL11926255 0.90 SENP2 (0.64) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL15358807 0.90 SENP2 (0.53) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL14923354 0.89 SENP2 (0.60) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL15386696 0.88 ALDH1A1 (0.58) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL944050 0.88 ENPP2 (0.54) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL11128580 0.88 ENPP2 (0.54) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL14469779 0.87 ALDH1A1 (0.58) SENP2SUMO2SUMO1SENP7ATIC
SCHEMBL13265421 0.86 ALDH1A1 (0.57) SENP2SUMO2SUMO1SENP7ATIC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3015516-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL Nippon Kayaku Kabushiki Kaisha (JP) 2016-05-04 EP disclosed
WO-2015020222-A1 INK COMPOSITION, INK JET RECORDING METHOD USING SAME, AND COLORED MATERIAL 日本化薬株式会社 (JP) 2015-02-12 WO disclosed
EP-2589631-B1 INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY NIPPON KAYAKU KK (JP) 2014-08-20 EP disclosed
US-8512462-B2 Azo compounds, ink compositions, and colored bodies NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2013-08-20 US disclosed
EP-2589631-A1 INK COMPOSITION, INKJET RECORDING METHOD AND COLORED BODY Nippon Kayaku Kabushiki Kaisha (JP) 2013-05-08 EP disclosed
US-20120202019-A1 AZO COMPOUNDS, INK COMPOSITIONS, AND COLORED BODIES NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-08-09 US disclosed
EP-2471874-A1 AZO COMPOUNDS, INK COMPOSITIONS, AND COLORED BODIES Nippon Kayaku Kabushiki Kaisha (JP) 2012-07-04 EP disclosed
US-8167991-B2 Trisazo compound, ink composition, recording method, and colored article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2012-05-01 US disclosed
EP-1767585-B1 AZO COMPOUND, INK COMPOSITION, AND COLORED OBJECT NIPPON KAYAKU KK (JP) 2011-08-03 EP disclosed
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2009-03-05 US disclosed
US-7427319-B2 Azo compound, ink composition, and colored object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2008-09-23 US disclosed
US-20070257975-A1 Azo Compound, Ink Composition, and Colored Object NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2007-11-08 US disclosed
EP-1767585-A1 AZO COMPOUND, INK COMPOSITION, AND COLORED OBJECT Nippon Kayaku Kabushiki Kaisha (JP) 2007-03-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062545-A1 Trisazo Compound, Ink Composition, Recording Method, and Colored Article JAK1, TMT1A, CDK1 SENP2 4015/4885SUMO2 2015/4885SUMO1 426/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.